Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-07-18
1999-10-05
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514249, 514253, 514255, 540470, 540575, 544356, 544359, 544295, 544360, 544362, 544363, 544370, 544393, A61K 31495, C07D295135, C07D40112, C07D40310
Patent
active
059624558
ABSTRACT:
This invention encompasses compounds of the formula ##STR1## and the pharmaceutically acceptable salts thereof wherein X.sub.1, X.sub.2, X.sub.3 represent organic or inorganic substituents, n is 1, 2, or 3, m is 2, 3, or 4, R.sub.1 -R.sub.4 are hydrogen or organic substituents, and B is nitrogen, carbon, sulfur or oxygen, useful in the diagnosis and treatment of feeding disorders such as obesity and bulimia and cardiovascular diseases such as essential hypertension and congestive heart failure due to the binding of these compounds to mammalian Neuropeptide Y1 receptors.
REFERENCES:
Gehlert et al., Exp. Opin. Invest Drugs, 6 (12), pp. 1827-1838, 1997.
Grundemar et al, TIPS 15, pp. 153-159, 1994.
Blum Charles A.
Hutchison Alan
Peterson John M.
Bernhardt Emily
Neurogen Corporation
LandOfFree
Certain substituted benzylamine derivatives a new class of neuro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain substituted benzylamine derivatives a new class of neuro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain substituted benzylamine derivatives a new class of neuro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171672